From the University of Maryland, he received a Bachelor of Science in Biochemistry and Master of Science in Molecular Biology. From Walden University, he received a Master of Public Health and PhD in Epidemiology. In 1993, he was one of the founders and first employee of Genox Corporation, a biotech startup company in Baltimore, Maryland where he worked for seven years as Lab Manager and Director of Research developing clinical assay tests to measure oxidative damage and antioxidants. In June 2000, he accepted a Biologist position at the National Institute on Aging in Baltimore, working with Dr. Mark P. Mattson in the Laboratory of Neuroscience where he has focused his research on the root causes of aging and neurodegenerative diseases for 20 years until Dr. Mattson’s retirement. Currently, he is working in the Laboratory of Clinical Investigation/Diabetes Section/Lipid Peroxidation Unit under Dr. Chris E. Ramsden developing full profile HPLC/MS/MS methods and running clinical samples to study the effects of endocannabinoids on pain and age-related insulin resistance (type 2) diabetes. His long-standing research interests continue to be in understanding the mechanism/s that regulate the rate of developmental milestones via the epigenetic clock (i.e. heterochrony), particularly in neurons during the progressive evolution of neoteny and lifespan that has occurred in simian, ape, and human.